Thursday, September 3, 2026

FDA screens GLP-! Ingredients at the Border and Warns of Vials Labeled with Pharmacies That Do Not Exist Published Sep 02, 2026 3:30 PM EDT By Dorothy Brooks

 


1 day ago — DA has an import alert on GLP-1 ingredients with quality concerns and warns of fraudulent compounded semaglutide carrying false pharmacy names.

No comments: